It has been reported that high levels of TGF‐β in tumor microenvironment and plasma were correlated with cancer progression, metastasis, and poor prognosis32, 33, 34 which is rather attributed from TGF‐β‐mediated chemoresistance.35, 36, 37. This evidence concerns the gene TGFB1 and cancer.